Nano-X Imaging (NNOX) Competitors $6.76 +0.19 (+2.89%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends NNOX vs. RXST, INMD, MDXG, ESTA, BLFS, PLSE, AORT, EMBC, CBLL, and LQDAShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia Nano-X Imaging (NASDAQ:NNOX) and RxSight (NASDAQ:RXST) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, community ranking, valuation, earnings, analyst recommendations and media sentiment. Do insiders & institutionals have more ownership in NNOX or RXST? 21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by insiders. Comparatively, 9.4% of RxSight shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer NNOX or RXST? Nano-X Imaging currently has a consensus price target of $12.00, indicating a potential upside of 77.51%. RxSight has a consensus price target of $59.00, indicating a potential upside of 75.28%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than RxSight.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00RxSight 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is NNOX or RXST more profitable? RxSight has a net margin of -23.92% compared to Nano-X Imaging's net margin of -465.38%. RxSight's return on equity of -14.00% beat Nano-X Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-465.38% -27.63% -24.72% RxSight -23.92%-14.00%-12.51% Does the media favor NNOX or RXST? In the previous week, RxSight had 11 more articles in the media than Nano-X Imaging. MarketBeat recorded 11 mentions for RxSight and 0 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.05 beat RxSight's score of 0.05 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Overall Sentiment Nano-X Imaging Neutral RxSight Neutral Which has preferable earnings and valuation, NNOX or RXST? RxSight has higher revenue and earnings than Nano-X Imaging. RxSight is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$10.68M36.57-$60.78M-$0.85-7.95RxSight$128.29M10.57-$48.61M-$0.83-40.55 Does the MarketBeat Community favor NNOX or RXST? RxSight received 17 more outperform votes than Nano-X Imaging when rated by MarketBeat users. However, 70.73% of users gave Nano-X Imaging an outperform vote while only 69.70% of users gave RxSight an outperform vote. CompanyUnderperformOutperformNano-X ImagingOutperform Votes2970.73% Underperform Votes1229.27% RxSightOutperform Votes4669.70% Underperform Votes2030.30% Which has more volatility & risk, NNOX or RXST? Nano-X Imaging has a beta of 2.02, meaning that its share price is 102% more volatile than the S&P 500. Comparatively, RxSight has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. SummaryRxSight beats Nano-X Imaging on 11 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingX IndustryBusiness SectorNASDAQ ExchangeMarket Cap$390.59M$12.83B$7.15B$9.08BDividend YieldN/A1.86%2.34%4.22%P/E Ratio-7.9521.6028.1417.18Price / Sales36.5710.48403.34116.83Price / CashN/A12.7731.0037.86Price / Book1.902.505.814.78Net Income-$60.78M$273.70M$125.99M$225.60M7 Day Performance-1.89%-4.10%4.01%-1.23%1 Month Performance10.91%-6.80%8.75%3.36%1 Year Performance-2.03%23.47%19.18%16.59% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging2.3594 of 5 stars$6.76+2.9%$12.00+77.5%+2.9%$390.59M$10.68M-7.95190Positive NewsRXSTRxSight2.9562 of 5 stars$38.75+3.9%$62.13+60.3%-11.8%$1.56B$89.08M-46.59220Analyst DowngradeGap DownINMDInMode3.6341 of 5 stars$18.18-0.4%$22.60+24.3%-21.7%$1.53B$423.75M9.87480Positive NewsMDXGMiMedx Group2.8137 of 5 stars$9.52+3.9%$12.00+26.1%+1.7%$1.40B$342.80M16.65895ESTAEstablishment Labs2.5211 of 5 stars$46.84+1.8%$60.60+29.4%+73.3%$1.31B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2666 of 5 stars$27.44+2.8%$28.29+3.1%+79.4%$1.27B$146.96M-25.19409Analyst ForecastInsider TradeNews CoverageGap DownPLSEPulse Biosciences1.8696 of 5 stars$20.12+14.0%N/A+56.3%$1.24B$700,000.000.00140Insider TradeNews CoverageAORTArtivion2.2159 of 5 stars$29.25+1.1%$31.80+8.7%+59.5%$1.23B$384.90M-1,446.501,500Positive NewsEMBCEmbecta3.7712 of 5 stars$19.90+2.0%$23.00+15.6%+13.5%$1.16B$1.12B14.712,200Short Interest ↓CBLLCeriBellN/A$28.70-1.8%$32.60+13.6%N/A$1.03B$60.04M0.00N/ALQDALiquidia3.4225 of 5 stars$11.14+2.0%$24.00+115.4%+3.7%$942.86M$15.61M-6.7050Analyst ForecastNews Coverage Related Companies and Tools Related Companies RxSight Competitors InMode Competitors MiMedx Group Competitors Establishment Labs Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Artivion Competitors Embecta Competitors CeriBell Competitors Liquidia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NNOX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
